| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |